cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ Comment “curious” for the full newsletter. 👇 There's a new metabolic regulator making waves. In preclinical studies, it: ↑ grip strength ~40%, ↑ muscle size, ↑ endurance, ↓ fat mass It may Emerging opportunities for nicotinamide N-methyltransferase

Approximately one year later, he experienced a severe worsening of his previously very mild neuropathy, and lab evaluation yielded a serum B12 of 220 pmol/l (which is normal, remember!?), but an elevated serum MMA of 1300 nmol/l, supporting the existence of true B12 deficiency

Research and Evidence AHK-Cu has a smaller research base than GHK-Cu, which has been studied since 1973

It is available as an oral dietary supplement in tablet form, or doctors can also prescribe it as a shot

Key gaps to address: dose-response in humans, safety/tolerability profiles across populations, interaction effects in stacks, and long-term cardiometabolic outcomes

Please confirm both statements and select a research type.

2022 Jan;15(1):e247660